L-carnitine to protect kidneys during cisplatin chemo
Part of Kidney & urinary clinical trials.
This trial tests if a supplement called L-carnitine can help prevent kidney damage caused by the chemotherapy drug cisplatin. It may be an option for newly diagnosed cancer patients who need cisplatin treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are newly diagnosed with cancer and need to get a chemotherapy drug called cisplatin.
- You are between 18 and 75 years old.
- Your kidneys are working well (a blood test will check this).
- You will receive at least 3 cycles of cisplatin.
- You have no other serious heart or lung problems, no history of kidney disease, and are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking vitamin C and coenzyme Q10 can help protect your kidneys while you receive chemotherapy with cisplatin and gemcitabine. It may reduce the risk of kidney damage from these treatments.
This study tests whether a supplement called alpha-lipoic acid can help protect your kidneys from damage caused by cisplatin, a common chemotherapy drug. If it works, it could reduce side effects and help you tolerate your cancer treatment better.
This study tests whether a natural supplement made from citrus plant compounds (diosmin and hesperidin) can protect your kidneys from damage caused by platinum-based chemotherapy drugs. Platinum chemotherapy is effective against many cancers but can harm kidney function over time.
This trial tests whether pantoprazole can help prevent kidney damage caused by a chemotherapy drug called cisplatin. It may help protect kidney function in people with head and neck cancer receiving cisplatin.
This study tests whether a supplement called N-acetylcysteine (a type of antioxidant) can help protect the kidneys during cisplatin chemotherapy. Cisplatin is a common cancer drug but can sometimes harm the kidneys, so this trial aims to see if adding this supplement reduces that risk.
This study looks at how cisplatin chemotherapy affects the kidneys. It may help doctors better predict and protect against kidney damage when patients start cisplatin.
Hear when a new Nephrotoxicity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.